Evidence map›Paper›PMID 41152733›Full record

ArticleBMC microbiology2025

Molecular epidemiology of tuberculosis in Western Burkina Faso: insights from a MIRU-VNTR study.

Yi Yè Aburi André Nagalo, Odilon D Kaboré, Anselme Millogo, Adama Sourabié, Emmanuel Zongo, Cheick Ahmed Ouattara, Yacouba Sawadogo, Jacques Kaboré, Emile Birba, Armel Poda and 5 more

Abstract read
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yi Yè Aburi André NagaloLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso. nagaloandre@gmail.com.ORCID 0000-0002-7862-7634
Odilon D KaboréLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.
Anselme MillogoService de Bactériologie Virologie, Département des laboratoires, CHU Sourô Sanou, Bobo- Dioulasso, 01 PO 676, Burkina Faso.
Adama SourabiéLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.
Emmanuel ZongoLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.
Cheick Ahmed OuattaraLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.
Yacouba SawadogoLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.
Jacques KaboréUnité de Formation et de Recherche en Sciences de la Vie et de la Terre, Université Nazi BONI, 01 PO 1091, Bobo-Dioulasso, Burkina Faso.
Emile BirbaLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.
Armel PodaLaboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.
Adrien Marie Gaston BelemInstitut de développement rural, Université Nazi BONI, Bobo-Dioulasso, 01 PO 1091, Burkina Faso.
Jonathan HoffmannDirection médicale et scientifique, Fondation Mérieux, Lyon, France.
Christian CarrièreMIVEGEC, IRD, CNRS, Université de Montpellier, 163 rue Auguste Broussonnet, Montpellier, 34090, France.
Sylvain Godreuil *MIVEGEC, IRD, CNRS, Université de Montpellier, 163 rue Auguste Broussonnet, Montpellier, 34090, France.
Abdoul-Salam Ouédraogo *Laboratoire des Pathogènes Émergents et Réémergents (LaPathER), Université Nazi BONI, Bobo-Dioulasso, 01 PO 676, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTuberculosis (TB) remains a significant public health challenge in Burkina Faso, with limited molecular epidemiology data available to track strain diversity and transmission patterns. This study aims to characterize the genetic diversity of Mycobacterium tuberculosis complex (MTBC) isolates circulating in Burkina Faso via Mycobacterial Interspersed Repetitive-Unit Variable-Number Tandem-Repeat (MIRU-VNTR) typing.

methodsGenotyping via the MIRU-VNTR technique, which is based on 24 loci, was performed via PCR amplification of DNA extracts from 80 MTBC isolates, followed by agarose gel electrophoresis. The genotypes obtained were identified via comparison with reference strains in the database via the MIRU VNTRplus web application. This study assessed strain diversity, clustering rates, and potential transmission patterns in the study area.

resultsAmong the 80 isolates, 94.5% were identified as M. tuberculosis sensu stricto, while 2.7% were M. africanum and 2.7% were M. bovis. The predominant lineages were Cameroon (26.3%), Ghana (26.3%), and Haarlem (20%), with the Beijing lineage being rare (1.25%). A low clustering rate of 2.5% was observed. The average discriminating power (allelic diversity index) was 0.444. Eight loci were highly discriminative (h ≥ 0. 6) versus 3 loci that were weakly discriminating (h < 0.3).

conclusionThis study provides new insights into the genetic diversity and transmission dynamics of MTBC strains in Burkina Faso. While the observed low clustering suggests limited recent TB transmission, the findings require further validation through larger-scale studies incorporating whole-genome sequencing (WGS). Understanding TB strain diversity is crucial for optimizing diagnostic strategies and TB control policies in West Africa.

Indexed as

Minisatellite RepeatsMycobacterium tuberculosisTuberculosisAdolescentAdultBurkina FasoChildDNA, BacterialFemaleGenetic VariationGenotypeHumansMaleMiddle AgedMolecular EpidemiologyPhylogenyDNA, BacterialBurkina fasoMIRU-VNTRMolecular epidemiologyMycobacterium tuberculosis complexTuberculosis transmission

Identifiers

PMID41152733
PMCPMC12570662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.